IMMUNE-INFLAMMATORY AND GENETIC FACTORS IN THE DEVELOPMENT OF ALCOHOLIC LIVER FIBROSIS ArticleIvanov A.S., Garmasch I.V., Arisheva O.S., Terebilina N.N., Baronets V.Yu., Peregud D.I., Kobalava Zh.D.Клиническая фармакология и терапия. Том 27. 2018. С. 30-36
ABOUT FUNDAMENTAL AND CLINICAL ASPECTS OF MAGNESIUM AND RIBOLAVINE SYNERGIC ACTION IN THERAPEUTIC PRACTICE ArticleGromova O.A., Torshin I.J., Kobalava Z.D., Sorokina M.A.Терапия. 2018. С. 119-131
ASSOCIATION OF FRAILTY WITH THE RISK OF ISCHEMIC AND HEMORRAGIC EVENTS IN THE ELDERLY PATIENTS WITH ACUTE CORONARY SYNDROME ArticleSoselia N.N., Bagmanova N.Kh., Villevalde S.V., Kobalava Zh.D.Клиническая фармакология и терапия. Том 27. 2018. С. 27-32
EXPERIENCE OF HOSPITAL INITIATION OF SACUBITRIL/VALSARTAN IN A FEMALE PATIENT AFTER ACUTE DECOMPENSATED HEART FAILURE ArticleГалочкин С.А., Лукина О.И., Мерай И.А., Виллевальде С.В., Кобалава Ж.Д.Kardiologiia. Том 58. 2018. С. 60-64
PHENOTYPES AND PROGNOSTIC VALUE OF CARDIOHEPATIC SYNDROME IN DECOMPENSATED HEART FAILURE ArticleSolovieva A.E., Villevalde S.V., Kobalava Z.D.Неотложная кардиология. 2018. С. 32-39
ECHOCARDIOGRAPHIC CAPABILITIES FOR THE ASSESSMENT OF RIGHT VENTRICULAR FUNCTION AND RIGHT VENTRICULAR-PULMONARY ARTERY COUPLING IN PATIENTS WITH CHRONIC HEART FAILURE ArticleIslamova M.R., Lazarev P.V., Safarova A.F., Kobalava Zh.D.Кардиология: новости, мнения, обучение. 2018. С. 51-58
RISK ASSESSMENT SCALE FOR DETECTION OF COMMUNITY-ACQUIRED ACUTE KIDNEY INJURY IN PATIENTS ADMITTED WITH CARDIAC DISEASES ArticleAvdoshina S., Lobzhanidze B., Efremovtseva M., Villevalde S., Kobalava Z.European Journal of Heart Failure. Том 20. 2018. С. 612-612
FRAILTY IS ASSOCIATED WITH MORTALITY AND HEMORRHAGIC RISK IN ELDERLY PATIENTS WITH ACUTE CORONARY SYNDROME ArticleSoseliya N.NN., Babaeva L., Bagmanova N., Villevalde S., Kobalava Z.European Journal of Heart Failure. Том 20. 2018. С. 123-123
ANTICOAGULANT THERAPY FOR CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION: THE AXIS OF ROTATION BETWEEN THE POLES OF RISK ArticleKobalava Z.D., Shavarov A.A.Евразийский кардиологический журнал. 2018. С. 64-83
PROBLEMS OF ANTICOAGULATION THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION: ROLE OF RIVAROXABAN ArticleКобалава Ж.Д., Виллевальде С.В., Троицкая Е.А.Kardiologiia. Том 58. 2018. С. 33-41
URINE BIOMARKERS AS DETERMINANTS OF POOR OUTCOMES IN PATIENTS WITH ACUTE KIDNEY INJURY AND HEART FAILURE WITH MID-RANGE EJECTION FRACTION ArticleKlimenko A., Villevalde S., Kobalava Z.European Journal of Heart Failure. Том 20. 2018. С. 413-413
CHARACTERISTICS AND CLINICAL ASSOCIATIONS OF ARTERIAL STIFFNESS AND SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS ArticleTroitskaya E.A., Velmakin S.V., Villevalde S.V., Kobalava Zh.D.Kardiologiia. Том 58. 2018. С. 46-54
CARDIAC DYSFUNCTION IN ALCOHOLIC LIVER CIRRHOSIS ArticleIvanov A.S., Romanova V.A., Kolesnikova I.A., Arisheva O.S., Garmash I.V., Kobalava Z.D.Экспериментальная и клиническая гастроэнтерология. 2018. С. 52-57
SGLT2 INHIBITORS: RATIONALE AND PERSPECTIVES OF USE IN HEART FAILURE ArticleКобалава Ж.Д., Лазарев П.В., Виллевальде С.В.Kardiologiia. Том 58. 2018. С. 44-54
EFFECTS OF GLUCOSE LOWERING DRUGS ON CARDIOVASCULAR RISK IN TYPE 2 DIABETES MELLITUS: REALITIES AND PERSPECTIVES ArticleКобалава Ж.Д., Киякбаев Г.К.Kardiologiia. Том 58. 2018. С. 53-65